ATC Group: J07AG51 Haemophilus influenzae B, combinations with toxoids

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of J07AG51 in the ATC hierarchy

Level Code Title
1 J Antiinfectives for systemic use
2 J07 Vaccines
3 J07A Bacterial vaccines
4 J07AG Haemophilus influenzae B vaccines
5 J07AG51 Haemophilus influenzae B, combinations with toxoids

Active ingredients in J07AG51

Active Ingredient Description
Haemophilus influenzae B, combinations with toxoids

Medicines in this ATC group

Canada (CA)

Hong Kong (HK)

Ireland (IE)

New Zealand (NZ)

Poland (PL)

South Africa (ZA)

Turkey (TR)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.